insights_auto
Nega NVZMY oshdi 2,22%?
Batafsil oʻrganishchevron_right
NVZMY:OTCMKTS
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
68,59Â US$
arrow_upward
+2,22%(+1,49) 1K
15-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoNVZMY tikeri uchun statistika yaratilmoqda...
Ochish
69,05Â US$
Yuqori
69,15Â US$
Past
68,49Â US$
Bozor kapitali
183,47Â mlrd
Oʻrtacha hajm
22,98Â ming
Hajmi
26,20Â ming
52 haftalik eng yuqori
75,26Â US$
52 haftalik eng past
49,90Â US$
Beta
0,87
Muomaladagi aksiyalar
414,56Â mln
Xodimlar soni
11Â ming
Ochish
69,05Â US$
Yuqori
69,15Â US$
Past
68,49Â US$
Bozor kapitali
183,47Â mlrd
Oʻrtacha hajm
22,98Â ming
Hajmi
26,20Â ming
52 haftalik eng yuqori
75,26Â US$
52 haftalik eng past
49,90Â US$
Beta
0,87
Muomaladagi aksiyalar
414,56Â mln
Xodimlar soni
11Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
15 soat oldin
Novonesis stock stands 1.27 percent below its 52-week high
Profil
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR haqida
CEOEster Baiget
Xodimlar soni11,1Â ming
Asos solingan2000
Bosh ofislar-
SektorSpeciality chemicals
Veb-saytnovonesis.com